Rivastigmine

Carbamates Category tree

FDA Approved EMA Approved TΔ°TCK Approved
Molecular Formula: C14H22N2O2
Molecular Weight: 250.34
CAS: 123441-03-2
Rivastigmine 2D structure

2D Chemical Structure

What is it used for?

Alzheimer disease Dementia due to Parkinson disease

ATC Classification

N06DA03 — rivastigmine
N > N06 > N06D > N06DA > N06DA03
N06DA03 — rivastigmine
N > N06 > N06D > N06DA > N06DA03

Unlock the full monograph

Access the complete clinical dataset for Rivastigmine β€” 1 detailed record and 9 brand names.

Mechanism of action
Pharmacokinetics & pharmacodynamics
Per-route PK parameters
Dosing regimens
Approvals from 10 regulators
Pregnancy & lactation safety
Drug-drug interactions
Food & disease interactions
Lab test interactions
Side effects & black-box warnings
Pharmacogenomics (PharmGKB, CPIC)
3D structure & physicochemistry
Products, formulations & pricing history
SGK reimbursement status, EK-4/A products & SUT conditions (TΓΌrkiye)
Patents & clinical trials
Literature & safety alerts

This preview is for informational purposes only. The full monograph is intended as a reference for licensed healthcare professionals.